The Effect of Diaphragmatic Respiratory Exercise Training on Clinical Symptoms, Quality of Life and Referral to physician in The Gastro-esophageal Reflux Patients (GERD)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190727044341N2

Enrollment

146

Registered

2020-05-01

Start date

2020-08-21

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastro-esophageal reflux disease. Gastro-esophageal reflux disease

Interventions

Intervention 1: Control group: No intervention will be made in this group. Intervention 2: Intervention group: Diaphragmatic breathing exercises will be taught and performed in the intervention group.

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Criteria for entering the study: Patients with second-degree gastroesophageal reflux disease who need medication in addition to lifestyle changes. The desire to participate in the study Age 20-60

Exclusion criteria

Exclusion criteria: Criteria for not entering the study: the presence of other chronic diseases that affect quality of life (cardiovascular disease, chronic kidney disease, chronic obstructive pulmonary disease, cirrhosis, rheumatoid disease, a history of malignancy, scleroderma, diabetes and a history of stroke Brain) Pregnancy History of upper gastrointestinal surgery BMI above 35 and below 18 Dissatisfaction with studying

Design outcomes

Primary

Measure	Time frame
Re-visit to the doctor: In this study, re-referral to the doctor will be reported using patients' self-report after the intervention and follow-up. Timepoint: Before the study, one and six months later. Method of measurement: Self-report.;Clinical Symptoms: In this study, clinical symptoms will be measured using the Reflux Disease (RDQ) questionnaire. The Reflux Disease (RDQ) questionnaire includes questions about heartburn, regurgitation, and dyspnea based on the frequency and severity of symptoms. The scores of each question are in the Likert range from zero to five for the frequency and severity of the symptoms, and the higher the score of the questionnaire, the greater the severity of the symptoms or the greater the frequency of symptoms. Timepoint: Before the study, one and six months later. Method of measurement: Reflux Disease Questionnaire (RDQ).;Quality of life: In this study, GERD-HRQL questionnaire is used to measure this variable. This questionnaire includes ten questions about the symptoms of the disease from 0 (asymptomatic) to 5 (inability to perform daily activities). The score from these ten questions ranges from zero (best) to 45 (worst). Timepoint: Before the study, one and six months later. Method of measurement: GERD-HRQL Questionnaire.	—

Measure

Time frame

Re-visit to the doctor: In this study, re-referral to the doctor will be reported using patients' self-report after the intervention and follow-up. Timepoint: Before the study, one and six months later. Method of measurement: Self-report.;Clinical Symptoms: In this study, clinical symptoms will be measured using the Reflux Disease (RDQ) questionnaire. The Reflux Disease (RDQ) questionnaire includes questions about heartburn, regurgitation, and dyspnea based on the frequency and severity of symptoms. The scores of each question are in the Likert range from zero to five for the frequency and severity of the symptoms, and the higher the score of the questionnaire, the greater the severity of the symptoms or the greater the frequency of symptoms. Timepoint: Before the study, one and six months later. Method of measurement: Reflux Disease Questionnaire (RDQ).;Quality of life: In this study, GERD-HRQL questionnaire is used to measure this variable. This questionnaire includes ten questions about the symptoms of the disease from 0 (asymptomatic) to 5 (inability to perform daily activities). The score from these ten questions ranges from zero (best) to 45 (worst). Timepoint: Before the study, one and six months later. Method of measurement: GERD-HRQL Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmin Hosseini Sooreh Bargh

Tehran University of Medical Sciences

aminhosseini835@gmail.com+98 21 6692 7171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026